APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kidney Transplant Rejection Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Kidney Transplant Rejection Therapeutics Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchKidney Transplant Rejection Therapeutics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Transplant Rejection Therapeutics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Kidney Transplant Rejection Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Transplant Rejection Therapeutics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Transplant Rejection Therapeutics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Kidney Transplant Rejection Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Kidney Transplant Rejection Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Kidney Transplant Rejection Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Kidney Transplant Rejection Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Kidney Transplant Rejection Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Kidney Transplant Rejection Therapeutics include Novartis AG, GlaxoSmithKline Plc, Pharming Group N.V., Pharmicell, OSE Immunotherapeutics, Opsona Therapeutics Limited, Noorik Biopharmaceuticals AG, Magnus Life Ltd and Mabtech Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Kidney Transplant Rejection Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Kidney Transplant Rejection Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for Kidney Transplant Rejection Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Kidney Transplant Rejection Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Kidney Transplant Rejection Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Kidney Transplant Rejection Therapeutics sales, projected growth trends, production technology, application and end-user industry.

Kidney Transplant Rejection Therapeutics Segment by Company

Novartis AG

GlaxoSmithKline Plc

Pharming Group N.V.

Pharmicell

OSE Immunotherapeutics

Opsona Therapeutics Limited

Noorik Biopharmaceuticals AG

Magnus Life Ltd

Mabtech Limited

Kyowa Hakko Kirin

Hansa Medical AB

Grifols, S.A.

Digna Biotech, S.L.

CSL Limited

Kidney Transplant Rejection Therapeutics Segment by Type

Cortina

Azathioprine

Cyclophosphamide

Cyclosporin A

Other

Kidney Transplant Rejection Therapeutics Segment by Application

Clinic

Hospital

ASCs

Others

Kidney Transplant Rejection Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Transplant Rejection Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Transplant Rejection Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Transplant Rejection Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Kidney Transplant Rejection Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Kidney Transplant Rejection Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney Transplant Rejection Therapeutics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Kidney Transplant Rejection Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cortina Major Manufacturers Table 3. Azathioprine Major Manufacturers Table 4. Cyclophosphamide Major Manufacturers Table 5. Cyclosporin A Major Manufacturers Table 6. Other Major Manufacturers Table 7. Global Kidney Transplant Rejection Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Clinic Major Manufacturers Table 9. Hospital Major Manufacturers Table 10. ASCs Major Manufacturers Table 11. Others Major Manufacturers Table 12. Kidney Transplant Rejection Therapeutics Industry Trends Table 13. Kidney Transplant Rejection Therapeutics Industry Drivers Table 14. Kidney Transplant Rejection Therapeutics Industry Opportunities and Challenges Table 15. Kidney Transplant Rejection Therapeutics Industry Restraints Table 16. Global Kidney Transplant Rejection Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2021-2026) Table 20. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2027-2032) Table 21. Global Kidney Transplant Rejection Therapeutics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Kidney Transplant Rejection Therapeutics Sales by Region (2021-2026) & (k units) Table 23. Global Kidney Transplant Rejection Therapeutics Sales by Region (2027-2032) & (k units) Table 24. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2021-2026) Table 25. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2027-2032) Table 26. Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Kidney Transplant Rejection Therapeutics Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Manufacturers (2021-2026) Table 30. Global Kidney Transplant Rejection Therapeutics Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Kidney Transplant Rejection Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Kidney Transplant Rejection Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Kidney Transplant Rejection Therapeutics Manufacturers, Product Type & Application Table 34. Global Kidney Transplant Rejection Therapeutics Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Kidney Transplant Rejection Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Kidney Transplant Rejection Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2026) Table 41. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2027-2032) Table 42. Global Kidney Transplant Rejection Therapeutics Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (k units) Table 44. Global Kidney Transplant Rejection Therapeutics Sales by Type (2027-2032) & (k units) Table 45. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2026) Table 46. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2027-2032) Table 47. Global Kidney Transplant Rejection Therapeutics Price by Type (2021-2026) & (US$/unit) Table 48. Global Kidney Transplant Rejection Therapeutics Price by Type (2027-2032) & (US$/unit) Table 49. Global Kidney Transplant Rejection Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2026) Table 53. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2027-2032) Table 54. Global Kidney Transplant Rejection Therapeutics Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (k units) Table 56. Global Kidney Transplant Rejection Therapeutics Sales by Application (2027-2032) & (k units) Table 57. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2026) Table 58. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2027-2032) Table 59. Global Kidney Transplant Rejection Therapeutics Price by Application (2021-2026) & (US$/unit) Table 60. Global Kidney Transplant Rejection Therapeutics Price by Application (2027-2032) & (US$/unit) Table 61. Novartis AG Company Information Table 62. Novartis AG Business Overview Table 63. Novartis AG Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Novartis AG Kidney Transplant Rejection Therapeutics Product Portfolio Table 65. Novartis AG Recent Development Table 66. GlaxoSmithKline Plc Company Information Table 67. GlaxoSmithKline Plc Business Overview Table 68. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product Portfolio Table 70. GlaxoSmithKline Plc Recent Development Table 71. Pharming Group N.V. Company Information Table 72. Pharming Group N.V. Business Overview Table 73. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product Portfolio Table 75. Pharming Group N.V. Recent Development Table 76. Pharmicell Company Information Table 77. Pharmicell Business Overview Table 78. Pharmicell Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Pharmicell Kidney Transplant Rejection Therapeutics Product Portfolio Table 80. Pharmicell Recent Development Table 81. OSE Immunotherapeutics Company Information Table 82. OSE Immunotherapeutics Business Overview Table 83. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product Portfolio Table 85. OSE Immunotherapeutics Recent Development Table 86. Opsona Therapeutics Limited Company Information Table 87. Opsona Therapeutics Limited Business Overview Table 88. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 90. Opsona Therapeutics Limited Recent Development Table 91. Noorik Biopharmaceuticals AG Company Information Table 92. Noorik Biopharmaceuticals AG Business Overview Table 93. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product Portfolio Table 95. Noorik Biopharmaceuticals AG Recent Development Table 96. Magnus Life Ltd Company Information Table 97. Magnus Life Ltd Business Overview Table 98. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product Portfolio Table 100. Magnus Life Ltd Recent Development Table 101. Mabtech Limited Company Information Table 102. Mabtech Limited Business Overview Table 103. Mabtech Limited Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Mabtech Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 105. Mabtech Limited Recent Development Table 106. Kyowa Hakko Kirin Company Information Table 107. Kyowa Hakko Kirin Business Overview Table 108. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product Portfolio Table 110. Kyowa Hakko Kirin Recent Development Table 111. Hansa Medical AB Company Information Table 112. Hansa Medical AB Business Overview Table 113. Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Hansa Medical AB Kidney Transplant Rejection Therapeutics Product Portfolio Table 115. Hansa Medical AB Recent Development Table 116. Grifols, S.A. Company Information Table 117. Grifols, S.A. Business Overview Table 118. Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Grifols, S.A. Kidney Transplant Rejection Therapeutics Product Portfolio Table 120. Grifols, S.A. Recent Development Table 121. Digna Biotech, S.L. Company Information Table 122. Digna Biotech, S.L. Business Overview Table 123. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product Portfolio Table 125. Digna Biotech, S.L. Recent Development Table 126. CSL Limited Company Information Table 127. CSL Limited Business Overview Table 128. CSL Limited Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. CSL Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 130. CSL Limited Recent Development Table 131. North America Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 132. North America Kidney Transplant Rejection Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 133. North America Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (k units) Table 134. North America Kidney Transplant Rejection Therapeutics Sales by Type (2027-2032) & (k units) Table 135. North America Kidney Transplant Rejection Therapeutics Sales Price by Type (2021-2026) & (US$/unit) Table 136. North America Kidney Transplant Rejection Therapeutics Sales Price by Type (2027-2032) & (US$/unit) Table 137. North America Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Kidney Transplant Rejection Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (k units) Table 140. North America Kidney Transplant Rejection Therapeutics Sales by Application (2027-2032) & (k units) Table 141. North America Kidney Transplant Rejection Therapeutics Sales Price by Application (2021-2026) & (US$/unit) Table 142. North America Kidney Transplant Rejection Therapeutics Sales Price by Application (2027-2032) & (US$/unit) Table 143. North America Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. North America Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. North America Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. North America Kidney Transplant Rejection Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 147. North America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 148. North America Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 149. North America Kidney Transplant Rejection Therapeutics Sales Price by Country (2021-2026) & (US$/unit) Table 150. North America Kidney Transplant Rejection Therapeutics Sales Price by Country (2027-2032) & (US$/unit) Table 151. United States Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 152. Canada Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 153. Mexico Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 154. Europe Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 155. Europe Kidney Transplant Rejection Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 156. Europe Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (k units) Table 157. Europe Kidney Transplant Rejection Therapeutics Sales by Type (2027-2032) & (k units) Table 158. Europe Kidney Transplant Rejection Therapeutics Sales Price by Type (2021-2026) & (US$/unit) Table 159. Europe Kidney Transplant Rejection Therapeutics Sales Price by Type (2027-2032) & (US$/unit) Table 160. Europe Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 161. Europe Kidney Transplant Rejection Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 162. Europe Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (k units) Table 163. Europe Kidney Transplant Rejection Therapeutics Sales by Application (2027-2032) & (k units) Table 164. Europe Kidney Transplant Rejection Therapeutics Sales Price by Application (2021-2026) & (US$/unit) Table 165. Europe Kidney Transplant Rejection Therapeutics Sales Price by Application (2027-2032) & (US$/unit) Table 166. Europe Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Europe Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Europe Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 170. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 171. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 172. Europe Kidney Transplant Rejection Therapeutics Sales Price by Country (2021-2026) & (US$/unit) Table 173. Europe Kidney Transplant Rejection Therapeutics Sales Price by Country (2027-2032) & (US$/unit) Table 174. Germany Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 175. France Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 176. U.K. Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 177. Italy Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 178. Russia Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 179. Spain Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 180. Netherlands Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 181. Switzerland Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 182. Sweden Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 183. Poland Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 184. China Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 185. China Kidney Transplant Rejection Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 186. China Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (k units) Table 187. China Kidney Transplant Rejection Therapeutics Sales by Type (2027-2032) & (k units) Table 188. China Kidney Transplant Rejection Therapeutics Sales Price by Type (2021-2026) & (US$/unit) Table 189. China Kidney Transplant Rejection Therapeutics Sales Price by Type (2027-2032) & (US$/unit) Table 190. China Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 191. China Kidney Transplant Rejection Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 192. China Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (k units) Table 193. China Kidney Transplant Rejection Therapeutics Sales by Application (2027-2032) & (k units) Table 194. China Kidney Transplant Rejection Therapeutics Sales Price by Application (2021-2026) & (US$/unit) Table 195. China Kidney Transplant Rejection Therapeutics Sales Price by Application (2027-2032) & (US$/unit) Table 196. Asia Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 197. Asia Kidney Transplant Rejection Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 198. Asia Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (k units) Table 199. Asia Kidney Transplant Rejection Therapeutics Sales by Type (2027-2032) & (k units) Table 200. Asia Kidney Transplant Rejection Therapeutics Sales Price by Type (2021-2026) & (US$/unit) Table 201. Asia Kidney Transplant Rejection Therapeutics Sales Price by Type (2027-2032) & (US$/unit) Table 202. Asia Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 203. Asia Kidney Transplant Rejection Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 204. Asia Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (k units) Table 205. Asia Kidney Transplant Rejection Therapeutics Sales by Application (2027-2032) & (k units) Table 206. Asia Kidney Transplant Rejection Therapeutics Sales Price by Application (2021-2026) & (US$/unit) Table 207. Asia Kidney Transplant Rejection Therapeutics Sales Price by Application (2027-2032) & (US$/unit) Table 208. Asia Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. Asia Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. Asia Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. Asia Kidney Transplant Rejection Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 212. Asia Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 213. Asia Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 214. Asia Kidney Transplant Rejection Therapeutics Sales Price by Country (2021-2026) & (US$/unit) Table 215. Asia Kidney Transplant Rejection Therapeutics Sales Price by Country (2027-2032) & (US$/unit) Table 216. Japan Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 217. South Korea Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 218. India Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 219. Australia Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 220. Taiwan Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 221. Southeast Asia Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 222. SAMEA Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 223. SAMEA Kidney Transplant Rejection Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 224. SAMEA Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (k units) Table 225. SAMEA Kidney Transplant Rejection Therapeutics Sales by Type (2027-2032) & (k units) Table 226. SAMEA Kidney Transplant Rejection Therapeutics Sales Price by Type (2021-2026) & (US$/unit) Table 227. SAMEA Kidney Transplant Rejection Therapeutics Sales Price by Type (2027-2032) & (US$/unit) Table 228. SAMEA Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 229. SAMEA Kidney Transplant Rejection Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 230. SAMEA Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (k units) Table 231. SAMEA Kidney Transplant Rejection Therapeutics Sales by Application (2027-2032) & (k units) Table 232. SAMEA Kidney Transplant Rejection Therapeutics Sales Price by Application (2021-2026) & (US$/unit) Table 233. SAMEA Kidney Transplant Rejection Therapeutics Sales Price by Application (2027-2032) & (US$/unit) Table 234. SAMEA Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. SAMEA Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. SAMEA Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. SAMEA Kidney Transplant Rejection Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 238. SAMEA Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 239. SAMEA Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 240. SAMEA Kidney Transplant Rejection Therapeutics Sales Price by Country (2021-2026) & (US$/unit) Table 241. SAMEA Kidney Transplant Rejection Therapeutics Sales Price by Country (2027-2032) & (US$/unit) Table 242. Brazil Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 243. Argentina Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 244. Chile Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 245. Colombia Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 246. Peru Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 247. Saudi Arabia Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 248. Israel Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 249. UAE Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 250. Turkey Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 251. Iran Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 252. Egypt Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Table 253. Key Raw Materials Table 254. Raw Materials Key Suppliers Table 255. Kidney Transplant Rejection Therapeutics Distributors List Table 256. Kidney Transplant Rejection Therapeutics Customers List Table 257. Research Programs/Design for This Report Table 258. Authors List of This Report Table 259. Secondary Sources Table 260. Primary Sources List of Figures Figure 1. Kidney Transplant Rejection Therapeutics Image Figure 2. Global Kidney Transplant Rejection Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Transplant Rejection Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cortina Image Figure 5. Azathioprine Image Figure 6. Cyclophosphamide Image Figure 7. Cyclosporin A Image Figure 8. Other Image Figure 9. Global Kidney Transplant Rejection Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Kidney Transplant Rejection Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. ASCs Image Figure 14. Others Image Figure 15. Global Kidney Transplant Rejection Therapeutics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Figure 17. Global Kidney Transplant Rejection Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2021-2032) Figure 20. Global Kidney Transplant Rejection Therapeutics Sales (2021-2032) & (k units) Figure 21. Global Kidney Transplant Rejection Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Kidney Transplant Rejection Therapeutics Sales YoY (2021-2032) & (k units) Figure 24. Europe Kidney Transplant Rejection Therapeutics Sales YoY (2021-2032) & (k units) Figure 25. China Kidney Transplant Rejection Therapeutics Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Kidney Transplant Rejection Therapeutics Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Sales YoY (2021-2032) & (k units) Figure 28. Global Kidney Transplant Rejection Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Kidney Transplant Rejection Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2032) Figure 34. Global Kidney Transplant Rejection Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2032) Figure 37. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2032) Figure 40. Global Kidney Transplant Rejection Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2032) Figure 43. North America Kidney Transplant Rejection Therapeutics Revenue Share by Type (2021-2032) Figure 44. North America Kidney Transplant Rejection Therapeutics Sales Share by Type (2021-2032) Figure 45. North America Kidney Transplant Rejection Therapeutics Revenue Share by Application (2021-2032) Figure 46. North America Kidney Transplant Rejection Therapeutics Sales Share by Application (2021-2032) Figure 47. North America Kidney Transplant Rejection Therapeutics Revenue Share by Country (2021-2032) Figure 48. North America Kidney Transplant Rejection Therapeutics Sales Share by Country (2021-2032) Figure 49. Europe Kidney Transplant Rejection Therapeutics Revenue Share by Type (2021-2032) Figure 50. Europe Kidney Transplant Rejection Therapeutics Sales Share by Type (2021-2032) Figure 51. Europe Kidney Transplant Rejection Therapeutics Revenue Share by Application (2021-2032) Figure 52. Europe Kidney Transplant Rejection Therapeutics Sales Share by Application (2021-2032) Figure 53. Europe Kidney Transplant Rejection Therapeutics Revenue Share by Country (2021-2032) Figure 54. Europe Kidney Transplant Rejection Therapeutics Sales Share by Country (2021-2032) Figure 55. China Kidney Transplant Rejection Therapeutics Revenue Share by Type (2021-2032) Figure 56. China Kidney Transplant Rejection Therapeutics Sales Share by Type (2021-2032) Figure 57. China Kidney Transplant Rejection Therapeutics Revenue Share by Application (2021-2032) Figure 58. China Kidney Transplant Rejection Therapeutics Sales Share by Application (2021-2032) Figure 59. Asia Kidney Transplant Rejection Therapeutics Revenue Share by Type (2021-2032) Figure 60. Asia Kidney Transplant Rejection Therapeutics Sales Share by Type (2021-2032) Figure 61. Asia Kidney Transplant Rejection Therapeutics Revenue Share by Application (2021-2032) Figure 62. Asia Kidney Transplant Rejection Therapeutics Sales Share by Application (2021-2032) Figure 63. Asia Kidney Transplant Rejection Therapeutics Revenue Share by Country (2021-2032) Figure 64. Asia Kidney Transplant Rejection Therapeutics Sales Share by Country (2021-2032) Figure 65. SAMEA Kidney Transplant Rejection Therapeutics Revenue Share by Type (2021-2032) Figure 66. SAMEA Kidney Transplant Rejection Therapeutics Sales Share by Type (2021-2032) Figure 67. SAMEA Kidney Transplant Rejection Therapeutics Revenue Share by Application (2021-2032) Figure 68. SAMEA Kidney Transplant Rejection Therapeutics Sales Share by Application (2021-2032) Figure 69. SAMEA Kidney Transplant Rejection Therapeutics Revenue Share by Country (2021-2032) Figure 70. SAMEA Kidney Transplant Rejection Therapeutics Sales Share by Country (2021-2032) Figure 71. Kidney Transplant Rejection Therapeutics Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Kidney Transplant Rejection Therapeutics Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Cortina
  • Azathioprine
  • Cyclophosphamide
  • Cyclosporin A
  • Other
Applications
  • Clinic
  • Hospital
  • ASCs
  • Others
Companies covered
  • Novartis AG
  • GlaxoSmithKline Plc
  • Pharming Group N.V.
  • Pharmicell
  • OSE Immunotherapeutics
  • Opsona Therapeutics Limited
  • Noorik Biopharmaceuticals AG
  • Magnus Life Ltd
  • Mabtech Limited
  • Kyowa Hakko Kirin
  • Hansa Medical AB
  • Grifols, S.A.
  • Digna Biotech, S.L.
  • CSL Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Kidney Transplant Rejection Therapeutics Market by Type
  3. 1.2.1 Global Kidney Transplant Rejection Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cortina
  5. 1.2.3 Azathioprine
  6. 1.2.4 Cyclophosphamide
  7. 1.2.5 Cyclosporin A
  8. 1.2.6 Other
  9. 1.3 Kidney Transplant Rejection Therapeutics Market by Application
  10. 1.3.1 Global Kidney Transplant Rejection Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 ASCs
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Kidney Transplant Rejection Therapeutics Market Dynamics
  1. 2.1 Kidney Transplant Rejection Therapeutics Industry Trends
  2. 2.2 Kidney Transplant Rejection Therapeutics Industry Drivers
  3. 2.3 Kidney Transplant Rejection Therapeutics Industry Opportunities and Challenges
  4. 2.4 Kidney Transplant Rejection Therapeutics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Kidney Transplant Rejection Therapeutics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Kidney Transplant Rejection Therapeutics Revenue by Region
  3. 3.2.1 Global Kidney Transplant Rejection Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Kidney Transplant Rejection Therapeutics Revenue by Region (2021-2026)
  5. 3.2.3 Global Kidney Transplant Rejection Therapeutics Revenue by Region (2027-2032)
  6. 3.2.4 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Kidney Transplant Rejection Therapeutics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Kidney Transplant Rejection Therapeutics Sales by Region
  9. 3.4.1 Global Kidney Transplant Rejection Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Kidney Transplant Rejection Therapeutics Sales by Region (2021-2026)
  11. 3.4.3 Global Kidney Transplant Rejection Therapeutics Sales by Region (2027-2032)
  12. 3.4.4 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturers
  2. 4.1.1 Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Kidney Transplant Rejection Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Kidney Transplant Rejection Therapeutics Sales by Manufacturers
  6. 4.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Kidney Transplant Rejection Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Kidney Transplant Rejection Therapeutics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Kidney Transplant Rejection Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Kidney Transplant Rejection Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Kidney Transplant Rejection Therapeutics Manufacturers, Product Type & Application
  13. 4.7 Global Kidney Transplant Rejection Therapeutics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Kidney Transplant Rejection Therapeutics Market CR5 and HHI
  16. 4.8.2 2025 Kidney Transplant Rejection Therapeutics Tier 1, Tier 2, and Tier 3
5 Kidney Transplant Rejection Therapeutics Market by Type
  1. 5.1 Global Kidney Transplant Rejection Therapeutics Revenue by Type
  2. 5.1.1 Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Kidney Transplant Rejection Therapeutics Sales by Type
  6. 5.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Kidney Transplant Rejection Therapeutics Price by Type
6 Kidney Transplant Rejection Therapeutics Market by Application
  1. 6.1 Global Kidney Transplant Rejection Therapeutics Revenue by Application
  2. 6.1.1 Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Kidney Transplant Rejection Therapeutics Sales by Application
  6. 6.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Kidney Transplant Rejection Therapeutics Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Kidney Transplant Rejection Therapeutics Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 GlaxoSmithKline Plc
  8. 7.2.1 GlaxoSmithKline Plc Company Information
  9. 7.2.2 GlaxoSmithKline Plc Business Overview
  10. 7.2.3 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product Portfolio
  12. 7.2.5 GlaxoSmithKline Plc Recent Developments
  13. 7.3 Pharming Group N.V.
  14. 7.3.1 Pharming Group N.V. Company Information
  15. 7.3.2 Pharming Group N.V. Business Overview
  16. 7.3.3 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product Portfolio
  18. 7.3.5 Pharming Group N.V. Recent Developments
  19. 7.4 Pharmicell
  20. 7.4.1 Pharmicell Company Information
  21. 7.4.2 Pharmicell Business Overview
  22. 7.4.3 Pharmicell Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pharmicell Kidney Transplant Rejection Therapeutics Product Portfolio
  24. 7.4.5 Pharmicell Recent Developments
  25. 7.5 OSE Immunotherapeutics
  26. 7.5.1 OSE Immunotherapeutics Company Information
  27. 7.5.2 OSE Immunotherapeutics Business Overview
  28. 7.5.3 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product Portfolio
  30. 7.5.5 OSE Immunotherapeutics Recent Developments
  31. 7.6 Opsona Therapeutics Limited
  32. 7.6.1 Opsona Therapeutics Limited Company Information
  33. 7.6.2 Opsona Therapeutics Limited Business Overview
  34. 7.6.3 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  36. 7.6.5 Opsona Therapeutics Limited Recent Developments
  37. 7.7 Noorik Biopharmaceuticals AG
  38. 7.7.1 Noorik Biopharmaceuticals AG Company Information
  39. 7.7.2 Noorik Biopharmaceuticals AG Business Overview
  40. 7.7.3 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product Portfolio
  42. 7.7.5 Noorik Biopharmaceuticals AG Recent Developments
  43. 7.8 Magnus Life Ltd
  44. 7.8.1 Magnus Life Ltd Company Information
  45. 7.8.2 Magnus Life Ltd Business Overview
  46. 7.8.3 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product Portfolio
  48. 7.8.5 Magnus Life Ltd Recent Developments
  49. 7.9 Mabtech Limited
  50. 7.9.1 Mabtech Limited Company Information
  51. 7.9.2 Mabtech Limited Business Overview
  52. 7.9.3 Mabtech Limited Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mabtech Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  54. 7.9.5 Mabtech Limited Recent Developments
  55. 7.10 Kyowa Hakko Kirin
  56. 7.10.1 Kyowa Hakko Kirin Company Information
  57. 7.10.2 Kyowa Hakko Kirin Business Overview
  58. 7.10.3 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product Portfolio
  60. 7.10.5 Kyowa Hakko Kirin Recent Developments
  61. 7.11 Hansa Medical AB
  62. 7.11.1 Hansa Medical AB Company Information
  63. 7.11.2 Hansa Medical AB Business Overview
  64. 7.11.3 Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hansa Medical AB Kidney Transplant Rejection Therapeutics Product Portfolio
  66. 7.11.5 Hansa Medical AB Recent Developments
  67. 7.12 Grifols, S.A.
  68. 7.12.1 Grifols, S.A. Company Information
  69. 7.12.2 Grifols, S.A. Business Overview
  70. 7.12.3 Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Grifols, S.A. Kidney Transplant Rejection Therapeutics Product Portfolio
  72. 7.12.5 Grifols, S.A. Recent Developments
  73. 7.13 Digna Biotech, S.L.
  74. 7.13.1 Digna Biotech, S.L. Company Information
  75. 7.13.2 Digna Biotech, S.L. Business Overview
  76. 7.13.3 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product Portfolio
  78. 7.13.5 Digna Biotech, S.L. Recent Developments
  79. 7.14 CSL Limited
  80. 7.14.1 CSL Limited Company Information
  81. 7.14.2 CSL Limited Business Overview
  82. 7.14.3 CSL Limited Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 CSL Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  84. 7.14.5 CSL Limited Recent Developments
8 North America
  1. 8.1 North America Kidney Transplant Rejection Therapeutics Market Size by Type
  2. 8.1.1 North America Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2032)
  3. 8.1.2 North America Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032)
  4. 8.1.3 North America Kidney Transplant Rejection Therapeutics Price by Type (2021-2032)
  5. 8.2 North America Kidney Transplant Rejection Therapeutics Market Size by Application
  6. 8.2.1 North America Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2032)
  7. 8.2.2 North America Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032)
  8. 8.2.3 North America Kidney Transplant Rejection Therapeutics Price by Application (2021-2032)
  9. 8.3 North America Kidney Transplant Rejection Therapeutics Market Size by Country
  10. 8.3.1 North America Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Kidney Transplant Rejection Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Kidney Transplant Rejection Therapeutics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Kidney Transplant Rejection Therapeutics Market Size by Type
  2. 9.1.1 Europe Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032)
  4. 9.1.3 Europe Kidney Transplant Rejection Therapeutics Price by Type (2021-2032)
  5. 9.2 Europe Kidney Transplant Rejection Therapeutics Market Size by Application
  6. 9.2.1 Europe Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032)
  8. 9.2.3 Europe Kidney Transplant Rejection Therapeutics Price by Application (2021-2032)
  9. 9.3 Europe Kidney Transplant Rejection Therapeutics Market Size by Country
  10. 9.3.1 Europe Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Kidney Transplant Rejection Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Kidney Transplant Rejection Therapeutics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Kidney Transplant Rejection Therapeutics Market Size by Type
  2. 10.1.1 China Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2032)
  3. 10.1.2 China Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032)
  4. 10.1.3 China Kidney Transplant Rejection Therapeutics Price by Type (2021-2032)
  5. 10.2 China Kidney Transplant Rejection Therapeutics Market Size by Application
  6. 10.2.1 China Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2032)
  7. 10.2.2 China Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032)
  8. 10.2.3 China Kidney Transplant Rejection Therapeutics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Kidney Transplant Rejection Therapeutics Market Size by Type
  2. 11.1.1 Asia Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032)
  4. 11.1.3 Asia Kidney Transplant Rejection Therapeutics Price by Type (2021-2032)
  5. 11.2 Asia Kidney Transplant Rejection Therapeutics Market Size by Application
  6. 11.2.1 Asia Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032)
  8. 11.2.3 Asia Kidney Transplant Rejection Therapeutics Price by Application (2021-2032)
  9. 11.3 Asia Kidney Transplant Rejection Therapeutics Market Size by Country
  10. 11.3.1 Asia Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Kidney Transplant Rejection Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Kidney Transplant Rejection Therapeutics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Kidney Transplant Rejection Therapeutics Market Size by Type
  2. 12.1.1 SAMEA Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Kidney Transplant Rejection Therapeutics Price by Type (2021-2032)
  5. 12.2 SAMEA Kidney Transplant Rejection Therapeutics Market Size by Application
  6. 12.2.1 SAMEA Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Kidney Transplant Rejection Therapeutics Price by Application (2021-2032)
  9. 12.3 SAMEA Kidney Transplant Rejection Therapeutics Market Size by Country
  10. 12.3.1 SAMEA Kidney Transplant Rejection Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Kidney Transplant Rejection Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Kidney Transplant Rejection Therapeutics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Kidney Transplant Rejection Therapeutics Value Chain Analysis
  2. 13.1.1 Kidney Transplant Rejection Therapeutics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Kidney Transplant Rejection Therapeutics Production Mode & Process
  6. 13.2 Kidney Transplant Rejection Therapeutics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Kidney Transplant Rejection Therapeutics Distributors
  9. 13.2.3 Kidney Transplant Rejection Therapeutics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst